Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Vasogen completes patient enrollment in congestive heart failure trial

June 27, 2001

Mechanism of blood pressure-lowering effects of PPARgamma agonists studied using GW-1929

June 26, 2001

Sphingomyelinase inhibitors discovered in natural sources at Kitasato Institute

June 25, 2001

Results for Vasogen's immune modulation therapy to be presented in September

June 25, 2001

Nortran's antiarrhythmic agent shows oral bioavailability

June 25, 2001

Vasopressin antagonists reported by Ortho-McNeil in patent literature

June 22, 2001

Numerous studies published recently on soon-to-be-introduced ARB olmesartan

June 22, 2001

PROGRESS trials show Aceon/diuretic combination reduces recurrent stroke by 50%

June 22, 2001

Grupo Vita uses Spain as reference member state for approval of enalapril/nitrendipine

June 21, 2001

Role of calcineurin in cardiac hypertrophy and subsequent heart failure

June 20, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...